{"id":"adipose-mesenchymal-stem-cells","safety":{"commonSideEffects":[{"rate":null,"effect":"Injection site reactions"},{"rate":null,"effect":"Fever"},{"rate":null,"effect":"Infection risk"}]},"_chembl":{"chemblId":"CHEMBL5315110","moleculeType":"Unknown"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Adipose mesenchymal stem cells (ASCs) are multipotent cells harvested from adipose tissue that exert therapeutic effects via paracrine secretion of anti-inflammatory cytokines and growth factors, modulation of immune responses, and direct differentiation into osteogenic, chondrogenic, and other lineages. These cells reduce inflammatory markers, promote angiogenesis, and support tissue regeneration in damaged or degenerative tissues.","oneSentence":"Adipose-derived mesenchymal stem cells promote tissue repair and regeneration through immunomodulation, anti-inflammatory signaling, and differentiation into functional cell types.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T00:44:13.823Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Tissue regeneration and repair (specific indication under investigation in Phase 3 trial not publicly detailed)"}]},"trialDetails":[{"nctId":"NCT06905834","phase":"PHASE2","title":"Evaluation of Allogenic Mesenchymal Stem Cell (MSC) Injection Therapy for Refractory Graft-versus-Host Disease (GVHD) Unresponsive to Conventional Treatments","status":"NOT_YET_RECRUITING","sponsor":"Instituto de Investigación Biomédica de Salamanca","startDate":"2026-05","conditions":"Dry Eye Disease (DED), Graft-Versus-Host Disease(GVHD)","enrollment":30},{"nctId":"NCT06798623","phase":"PHASE1","title":"Anterior Cruciate Ligament (ACL) Reconstruction With Autologous Fat Pad Derived Mesenchymal Stem Cells","status":"RECRUITING","sponsor":"The Methodist Hospital Research Institute","startDate":"2026-03-24","conditions":"Anterior Cruciate Ligament Reconstruction","enrollment":15},{"nctId":"NCT07487467","phase":"NA","title":"Autologous SVF Therapy for Type 2 Diabetes","status":"RECRUITING","sponsor":"Kaiser Clinic and Hospital","startDate":"2025-01-20","conditions":"Diabetes Mellitus, Type 2","enrollment":10},{"nctId":"NCT07048314","phase":"PHASE1, PHASE2","title":"Stem Cells for Erectile Dysfunction Post RALP","status":"NOT_YET_RECRUITING","sponsor":"The Methodist Hospital Research Institute","startDate":"2026-03-10","conditions":"Erectile Dysfunction, Prostate Cancer","enrollment":40},{"nctId":"NCT07474467","phase":"PHASE1, PHASE2","title":"Safety and Efficacy of Autologous Adipose-derived Mesenchymal Stem Cells Therapy in Adults With Atrophic Scars","status":"NOT_YET_RECRUITING","sponsor":"CellinCells","startDate":"2026-08-01","conditions":"Atrophic Scar","enrollment":31},{"nctId":"NCT07238062","phase":"","title":"\"An Intermediate Size Patient Population Expanded Access Protocol to Evaluate the Safety and Efficacy of Allogeneic HB-adMSCs (Hope Biosciences - Adipose Derived Mesenchymal Stem Cells) for the Treatment of Multiple System Atrophy.\"","status":"TEMPORARILY_NOT_AVAILABLE","sponsor":"Hope Biosciences Research Foundation","startDate":"","conditions":"Multiple System Atrophy","enrollment":""},{"nctId":"NCT06915233","phase":"PHASE3","title":"A Study of MACI in Patients Aged 17 to 65 Years With Symptomatic Chondral or Osteochondral Defects of the Ankle","status":"RECRUITING","sponsor":"Vericel Corporation","startDate":"2026-03","conditions":"Chondral Defect, Articular Cartilage Defect","enrollment":309},{"nctId":"NCT06654193","phase":"PHASE1, PHASE2","title":"Allogeneic HB-adMSCs vs Placebo for the Treatment of Acute Kidney Injury","status":"RECRUITING","sponsor":"Hope Biosciences LLC","startDate":"2026-02-01","conditions":"Acute Kidney Injury","enrollment":70},{"nctId":"NCT07434115","phase":"EARLY_PHASE1","title":"Orthobiological Therapies in Musculoskeletal Disorders","status":"NOT_YET_RECRUITING","sponsor":"PROREGEN","startDate":"2026-01-30","conditions":"Musculoskeletal Diseases or Conditions","enrollment":300},{"nctId":"NCT07077746","phase":"PHASE2","title":"HB-adMSCs for the Treatment of Crohn's Disease","status":"RECRUITING","sponsor":"Hope Biosciences Research Foundation","startDate":"2026-03","conditions":"Crohn Disease (CD)","enrollment":46},{"nctId":"NCT07377838","phase":"PHASE3","title":"Study of ADSTEM Injection for Patients With Moderate to Severe Subacute and Chronic Atopic Dermatitis","status":"NOT_YET_RECRUITING","sponsor":"EHL Bio Co., Ltd.","startDate":"2026-06","conditions":"Atopic Dermatitis","enrollment":286},{"nctId":"NCT06840275","phase":"PHASE2","title":"ASCs in Recently Diagnosed Non-ischemic Heart Failure","status":"NOT_YET_RECRUITING","sponsor":"Cell to Cure ApS","startDate":"2026-03-01","conditions":"Non-Ischemic Heart Failure, Reduced Ejection Fraction Heart Failure","enrollment":90},{"nctId":"NCT05553132","phase":"PHASE1","title":"A Study of REcycled CartiLage Auto/Allo IMplantation to Treat and Repair Focal Hip Cartilage Defects","status":"ACTIVE_NOT_RECRUITING","sponsor":"Daniel B. F. Saris","startDate":"2023-08-08","conditions":"Cartilage Defect","enrollment":15},{"nctId":"NCT06775964","phase":"PHASE1, PHASE2","title":"Stem Cell Therapy for Early Alzheimer's Disease","status":"RECRUITING","sponsor":"Paul E Schulz","startDate":"2026-02","conditions":"Cognitive Dysfunction","enrollment":12},{"nctId":"NCT07367815","phase":"PHASE1, PHASE2","title":"Allogeneic Adipose Tissue Derived-stem Cells in Alzheimer Disease","status":"NOT_YET_RECRUITING","sponsor":"University Hospital, Toulouse","startDate":"2026-03-01","conditions":"Alzheimer Disease","enrollment":9},{"nctId":"NCT06726538","phase":"PHASE1, PHASE2","title":"Investigating the Efficacy of Autologous, Adipose-derived Mesenchymal Stem Cell Therapy for the Treatment of Sexual Function Impairment in Women Aged 40-50","status":"COMPLETED","sponsor":"Vinmec Research Institute of Stem Cell and Gene Technology","startDate":"2023-10-01","conditions":"Female Sexual Dysfunction","enrollment":50},{"nctId":"NCT04312113","phase":"PHASE1","title":"Angiographic Delivery of AD-MSC for Ulcerative Colitis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Mayo Clinic","startDate":"2020-11-16","conditions":"Ulcerative Colitis","enrollment":20},{"nctId":"NCT04063215","phase":"PHASE1, PHASE2","title":"A Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Autologous Mesenchymal Stem Cell Therapy for the Treatment of Traumatic Brain Injury and Hypoxic-Ischemic Encephalopathy","status":"COMPLETED","sponsor":"Hope Biosciences LLC","startDate":"2020-01-01","conditions":"Traumatic Brain Injury","enrollment":24},{"nctId":"NCT07344324","phase":"NA","title":"Study Evaluating the Safety and Feasibility of Endoscopic Duodenal Injections of Autologous Mesenchymal Stem Cells","status":"NOT_YET_RECRUITING","sponsor":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","startDate":"2026-02-02","conditions":"Diabete Type 2, Insulin Resistant Diabetes (Mellitus), Obesity","enrollment":15},{"nctId":"NCT06623240","phase":"PHASE2","title":"HB-adMSCs vs Placebo for the Treatment of Juvenile Idiopathic Arthritis","status":"WITHDRAWN","sponsor":"Hope Biosciences Research Foundation","startDate":"2026-01","conditions":"Juvenile Idiopathic Arthritis (JIA)","enrollment":""},{"nctId":"NCT02808208","phase":"PHASE1","title":"Autologous Adipose Derived Mesenchymal Stem Cells (AMSC) in Reducing Hemodialysis Arteriovenous Fistula Failure","status":"ACTIVE_NOT_RECRUITING","sponsor":"Mayo Clinic","startDate":"2017-06-07","conditions":"End Stage Renal Disease (ESRD), Vascular Access Complication","enrollment":74},{"nctId":"NCT04995081","phase":"PHASE2","title":"Clinical Trial for Parkinson's Disease Using Allogeneic HB-adMSCs (Early and Moderate PD)","status":"COMPLETED","sponsor":"Hope Biosciences Research Foundation","startDate":"2021-07-16","conditions":"Parkinson Disease","enrollment":60},{"nctId":"NCT05595681","phase":"PHASE1","title":"Effect of Mesenchymal Stem Cells on Healing of Foot Ulcers in Diabetes Patients.","status":"TERMINATED","sponsor":"Cell to Cure ApS","startDate":"2022-12-15","conditions":"Diabetic Foot Ulcer, Mesenchymal Stromal Cells","enrollment":21},{"nctId":"NCT07290946","phase":"PHASE2","title":"Repeated Mesenchymal Stem Cell Therapy for Radiation-Induced Hyposalivation and Xerostomia in Head and Neck Cancer Survivors","status":"NOT_YET_RECRUITING","sponsor":"Christian von Buchwald","startDate":"2025-12","conditions":"Xerostomia Due to Hyposecretion of Salivary Gland, Xerostomia Due to Radiotherapy, Sjögren´s Syndrome","enrollment":100},{"nctId":"NCT07164482","phase":"","title":"Intermediate Size Patient Population Expanded Access Protocol to Evaluate HB-adMSCs for the Treatment of Patients With Traumatic or Nontraumatic Brain Injury","status":"AVAILABLE","sponsor":"Hope Biosciences Research Foundation","startDate":"","conditions":"Brain Injury","enrollment":""},{"nctId":"NCT02068794","phase":"PHASE1, PHASE2","title":"MV-NIS Infected Mesenchymal Stem Cells in Treating Recurrent Ovarian, Primary Peritoneal or Fallopian Tube Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Mayo Clinic","startDate":"2014-04-25","conditions":"Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube Mucinous Adenocarcinoma","enrollment":34},{"nctId":"NCT03608579","phase":"PHASE1","title":"Autologous Culture Expanded Adipose Derived MSCs for Treatment of Painful Hip OA","status":"ACTIVE_NOT_RECRUITING","sponsor":"Mayo Clinic","startDate":"2018-11-05","conditions":"Osteoarthritis, Hip","enrollment":24},{"nctId":"NCT05789394","phase":"PHASE1","title":"Allogenic Adipose-Derived Mesenchymal Stem Cells for the Treatment of Recurrent Glioblastoma or Recurrent Astrocytoma in Patients Undergoing Craniotomy","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2023-06-16","conditions":"Recurrent Glioblastoma, IDH-Wildtype, Recurrent Astrocytoma, IDH-Mutant, Grade 4, Astrocytoma, Grade IV","enrollment":20},{"nctId":"NCT04520373","phase":"PHASE2","title":"Autologous Adipose Derived Mesenchymal Stem Cells for Spinal Cord Injury Patients","status":"ACTIVE_NOT_RECRUITING","sponsor":"Mayo Clinic","startDate":"2020-06-25","conditions":"Spinal Cord Injuries, Paralysis","enrollment":40},{"nctId":"NCT02838069","phase":"PHASE2","title":"A Study Evaluating the Efficacy of a Single Injection Autologous Adipose Derived Mesenchymal Stromal Cells in Patients With Knee Osteoarthritis","status":"COMPLETED","sponsor":"University Hospital, Montpellier","startDate":"2016-09-20","conditions":"Osteoarthritis","enrollment":100},{"nctId":"NCT05154851","phase":"","title":"HBCMD01- Expanded Access for the Treatment of Congenital Muscular Dystrophy.","status":"NO_LONGER_AVAILABLE","sponsor":"Hope Biosciences Research Foundation","startDate":"","conditions":"Congenital Muscular Dystrophy Due to Lamin A/C Mutation","enrollment":""},{"nctId":"NCT04825613","phase":"","title":"\"Individual Patient Expanded Access IND to Treat Primary Lateral Sclerosis\"","status":"NO_LONGER_AVAILABLE","sponsor":"Hope Biosciences Research Foundation","startDate":"","conditions":"Primary Lateral Sclerosis, Adult, 1","enrollment":""},{"nctId":"NCT04064957","phase":"","title":"Individual Patient Expanded Access IND of Hope Biosciences Autologous Adipose-derived Mesenchymal Stem Cells for Spinal Cord Injury","status":"NO_LONGER_AVAILABLE","sponsor":"Hope Biosciences Research Foundation","startDate":"","conditions":"Spinal Cord Injuries","enrollment":""},{"nctId":"NCT04029896","phase":"","title":"Individual Patient Expanded Access IND of Hope Biosciences Autologous Adipose-derived Mesenchymal Stem Cells for the Treatment of Cerebral Palsy","status":"NO_LONGER_AVAILABLE","sponsor":"Hope Biosciences Research Foundation","startDate":"","conditions":"Cerebral Palsy","enrollment":""},{"nctId":"NCT04087889","phase":"","title":"Individual Patient Expanded Access IND of Hope Biosciences First Blood Relative Allogeneic Adipose-derived Mesenchymal Stem Cells (HB-adMSCs) for Pancreatic Cancer","status":"NO_LONGER_AVAILABLE","sponsor":"Hope Biosciences LLC","startDate":"","conditions":"Pancreatic Cancer","enrollment":""},{"nctId":"NCT04825626","phase":"","title":"An Expanded Access IND for the Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)","status":"NO_LONGER_AVAILABLE","sponsor":"Hope Biosciences Research Foundation","startDate":"","conditions":"Chronic Inflammatory Demyelinating Polyneuropathy","enrollment":""},{"nctId":"NCT04604288","phase":"","title":"Individual Patient Expanded Access IND of Autologous HB-adMSCS for the Treatment of Bilateral Knee Pain.","status":"NO_LONGER_AVAILABLE","sponsor":"Hope Biosciences Research Foundation","startDate":"","conditions":"Knee Pain Chronic, Osteo Arthritis Knee","enrollment":""},{"nctId":"NCT06056427","phase":"","title":"Intermediate Size Expanded Access Protocol Using Autologous HB-adMSCs for the Treatment of Parkinson's Disease","status":"NO_LONGER_AVAILABLE","sponsor":"Hope Biosciences Research Foundation","startDate":"","conditions":"Parkinson Disease","enrollment":""},{"nctId":"NCT05951777","phase":"PHASE2","title":"Autologous Adipose-Derived Mesenchymal Stem Cells for Chronic Traumatic Brain Injury","status":"RECRUITING","sponsor":"Hope Biosciences LLC","startDate":"2024-04-16","conditions":"Traumatic Brain Injury","enrollment":51},{"nctId":"NCT04772378","phase":"","title":"Intermediate Size Patient Population Expanded Access IND for the Treatment of Patients With Parkinson's Disease.","status":"NO_LONGER_AVAILABLE","sponsor":"Hope Biosciences Research Foundation","startDate":"","conditions":"Parkinson Disease","enrollment":""},{"nctId":"NCT04612465","phase":"PHASE3","title":"Clinical Study to Evaluate Efficacy and Safety of ASC and Fibringlue or Fibringlue in Patients With Crohn's Fistula","status":"ACTIVE_NOT_RECRUITING","sponsor":"Anterogen Co., Ltd.","startDate":"2020-01-09","conditions":"Crohn's Fistula","enrollment":46},{"nctId":"NCT04514952","phase":"","title":"Individual Patient Expanded Access IND of Autologous HBadMSCs for the Treatment of Amyotrophic Lateral Sclerosis","status":"NO_LONGER_AVAILABLE","sponsor":"Hope Biosciences Research Foundation","startDate":"","conditions":"Amyotrophic Lateral Sclerosis","enrollment":""},{"nctId":"NCT04064983","phase":"","title":"Individual Patient Expanded Access IND to Treat Polyneuropathy","status":"NO_LONGER_AVAILABLE","sponsor":"Hope Biosciences Research Foundation","startDate":"","conditions":"Polyneuropathies","enrollment":""},{"nctId":"NCT04228666","phase":"PHASE1, PHASE2","title":"A Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Autologous Mesenchymal Stem Cell Therapy (HB-adMSCs) for the Treatment of Alzheimer's Disease","status":"WITHDRAWN","sponsor":"Hope Biosciences LLC","startDate":"2020-03-01","conditions":"Alzheimer Disease","enrollment":""},{"nctId":"NCT03925649","phase":"","title":"Individual Patient Expanded Access IND of Hope Biosciences Autologous Adipose-derived Mesenchymal Stem Cells for Treatment of SCI","status":"NO_LONGER_AVAILABLE","sponsor":"Hope Biosciences LLC","startDate":"","conditions":"Spinal Cord Injury at C5-C7 Level","enrollment":""},{"nctId":"NCT04798066","phase":"","title":"Intermediate Size Expanded Access Protocol for the Treatment of Post-COVID-19 Syndrome","status":"NO_LONGER_AVAILABLE","sponsor":"Hope Biosciences Research Foundation","startDate":"","conditions":"Post COVID-19 Syndrome","enrollment":""},{"nctId":"NCT04711811","phase":"","title":"Individual Patient Expanded Access IND of HB-adMSCs for Chronic Musculoskeletal Pain.","status":"NO_LONGER_AVAILABLE","sponsor":"Hope Biosciences Research Foundation","startDate":"","conditions":"Chronic Pain","enrollment":""},{"nctId":"NCT04348435","phase":"PHASE2","title":"A Randomized, Double-Blind, Single Center, Efficacy and Safety Study of Allogeneic HB-adMSCs Against COVID-19.","status":"COMPLETED","sponsor":"Hope Biosciences Research Foundation","startDate":"2020-05-14","conditions":"COVID-19","enrollment":53},{"nctId":"NCT05116540","phase":"PHASE2","title":"Randomized Double-Blind Phase 2 Efficacy and Safety of Autologous HB-MSCs vs Placebo for Treatment of Multiple Sclerosis","status":"COMPLETED","sponsor":"Hope Biosciences Research Foundation","startDate":"2021-11-24","conditions":"Multiple Sclerosis","enrollment":24},{"nctId":"NCT05126563","phase":"PHASE2","title":"Randomized Double-Blind Phase 2 Study of Allogeneic HB-adMSCs for the Treatment of Chronic Post-COVID-19 Syndrome","status":"COMPLETED","sponsor":"Hope Biosciences Research Foundation","startDate":"2022-02-02","conditions":"Post COVID-19 Syndrome","enrollment":79},{"nctId":"NCT04362189","phase":"PHASE2","title":"Efficacy and Safety Study of Allogeneic HB-adMSCs for the Treatment of COVID-19","status":"TERMINATED","sponsor":"Hope Biosciences Research Foundation","startDate":"2020-06-30","conditions":"COVID-19","enrollment":48},{"nctId":"NCT04349631","phase":"PHASE2","title":"A Clinical Trial to Determine the Safety and Efficacy of HB-adMSCs to Provide Protection Against COVID-19","status":"COMPLETED","sponsor":"Hope Biosciences Research Foundation","startDate":"2020-04-20","conditions":"COVID-19","enrollment":51},{"nctId":"NCT04928287","phase":"PHASE2","title":"Randomized, Double-Blind Clinical Trial for Parkinson's Disease (Early and Moderate)","status":"COMPLETED","sponsor":"Hope Biosciences Research Foundation","startDate":"2021-06-28","conditions":"Parkinson Disease","enrollment":24},{"nctId":"NCT03691909","phase":"PHASE1, PHASE2","title":"Phase 1/2a Clinical Trial to Assess the Safety of HB-adMSCs for the Treatment of Rheumatoid Arthritis","status":"COMPLETED","sponsor":"Hope Biosciences LLC","startDate":"2018-09-25","conditions":"Rheumatoid Arthritis","enrollment":15},{"nctId":"NCT04569409","phase":"PHASE3","title":"Clinical Study to Evaluate Efficacy and Safety of ALLO-ASC-DFU in Patients With Diabetic Wagner Grade 2 Foot Ulcers.","status":"COMPLETED","sponsor":"Anterogen Co., Ltd.","startDate":"2020-07-14","conditions":"Diabetic Foot Ulcer","enrollment":104},{"nctId":"NCT06539429","phase":"PHASE1","title":"Clinical Study to Evaluate Efficacy and Safety of ANT-301 in Patients With Knee Osteoarthritis in Grade III/IV by K/L","status":"ACTIVE_NOT_RECRUITING","sponsor":"Anterogen Co., Ltd.","startDate":"2024-10-22","conditions":"Osteoarthritis, Knee","enrollment":6},{"nctId":"NCT07183384","phase":"PHASE1, PHASE2","title":"MSC Exosome Therapy for Post-Preeclampsia Endothelial Dysfunction","status":"RECRUITING","sponsor":"Universitas Padjadjaran","startDate":"2024-07-01","conditions":"Preeclampsia, Postpartum, Endothelial Injury","enrollment":80},{"nctId":"NCT07106229","phase":"PHASE3","title":"A Study to Investigate the Effectiveness, Safety, and Tolerability of MAG200 Solution for Intra-articular Injection Compared With Placebo in Participants Aged 35 to 75 Years of Age With Symptomatic Osteoarthritis of the Knee.","status":"NOT_YET_RECRUITING","sponsor":"Magellan Stem Cells","startDate":"2025-11","conditions":"Knee Osteoarthristis","enrollment":573},{"nctId":"NCT07161128","phase":"NA","title":"Gait Pattern Analysis After Arthroscopic Treament of Osteochondral Defects of Talus","status":"ENROLLING_BY_INVITATION","sponsor":"Gazi University","startDate":"2024-06-01","conditions":"Osteochondral Defects of Talus, Gait Analysis, Microfracture Procedure","enrollment":60},{"nctId":"NCT05344157","phase":"PHASE1, PHASE2","title":"A First-in-Human Study of XSTEM-OA in Patients With Knee Osteoarthritis","status":"COMPLETED","sponsor":"Xindu Pty Ltd","startDate":"2022-06-22","conditions":"Osteoarthritis, Knee","enrollment":24},{"nctId":"NCT07137130","phase":"NA","title":"Secretome TGF Beta 3","status":"NOT_YET_RECRUITING","sponsor":"Indonesia University","startDate":"2026-02-14","conditions":"Melasma","enrollment":34},{"nctId":"NCT06789302","phase":"PHASE2","title":"A Double-Blind, Randomized, Placebo-Controlled Phase IIa Clinical Trial to Evaluate the Safety and Efficacy of DT2-SCT in Subjects With Type 2 Diabetes Mellitus","status":"NOT_YET_RECRUITING","sponsor":"Global Institute of Stem Cell Therapy and Research","startDate":"2025-12","conditions":"Type 2 Diabetes Mellitus (T2DM)","enrollment":120},{"nctId":"NCT05308836","phase":"PHASE1","title":"Evaluate Safety of Adipose Derived Mesenchymal Stem Cell Transplantation for Type 1 Diabetes Treatment","status":"COMPLETED","sponsor":"Vinmec Research Institute of Stem Cell and Gene Technology","startDate":"2021-05-04","conditions":"Type 1 Diabetes","enrollment":10},{"nctId":"NCT03840343","phase":"PHASE1","title":"Patient-Derived Stem Cell Therapy for Diabetic Kidney Disease","status":"TERMINATED","sponsor":"Mayo Clinic","startDate":"2019-10-23","conditions":"Diabetic Kidney Disease, Diabetic Nephropathies, Diabetes Mellitus, Type 2","enrollment":2},{"nctId":"NCT04392206","phase":"PHASE1","title":"AMSC for Reducing Anastomotic Stenosis in Primary Arteriovenous Anastomoses","status":"RECRUITING","sponsor":"Houssam Farres, M.D.","startDate":"2020-05-15","conditions":"End Stage Renal Disease","enrollment":15},{"nctId":"NCT06210919","phase":"PHASE1","title":"Safety and Tolerability of Autologous Adipose-derived Mesenchymal Stem Cells Therapy in Adults With Atrophic Scars","status":"COMPLETED","sponsor":"CellinCells","startDate":"2023-12-06","conditions":"Atrophic Scar","enrollment":3},{"nctId":"NCT07104981","phase":"","title":"Retrospective Results of Micronized Adipose Tissue in Patients With Interstitial Cystitis","status":"COMPLETED","sponsor":"University of Roma La Sapienza","startDate":"2024-04-04","conditions":"Interstitial Cystitis/Painful Bladder Syndrome","enrollment":20},{"nctId":"NCT04368806","phase":"PHASE2, PHASE3","title":"A Phase 2b/3a Study to Evaluate the Efficacy and Safety of JointStem in Patients Diagnosed as Knee Osteoarthritis","status":"RECRUITING","sponsor":"Nature Cell Co. Ltd.","startDate":"2021-05-26","conditions":"Osteoarthritis, Knee","enrollment":140},{"nctId":"NCT06570291","phase":"PHASE3","title":"Allogenic Adipose-Derived Mesenchymal Stem Cells for the Treatment of Knee Osteoarthritis","status":"RECRUITING","sponsor":"Wuxi Cellular Biopharmaceutical Group Ltd.","startDate":"2025-02-28","conditions":"Knee Osteoarthritis","enrollment":520},{"nctId":"NCT07010926","phase":"PHASE2","title":"A Double-Blind, Randomized, Placebo-Controlled Phase II Clinical Trial to Evaluate the Safety and Efficacy of L2-01 in Subjects With Crohn's Disease","status":"NOT_YET_RECRUITING","sponsor":"L2 Bio, LLC","startDate":"2025-08-15","conditions":"Crohn&Amp;#39;s, Crohn&Amp;#39;s Disease (CD)","enrollment":120},{"nctId":"NCT04869761","phase":"PHASE1","title":"Stem Cell Therapy for Chronic Kidney Disease","status":"COMPLETED","sponsor":"LaTonya J. Hickson","startDate":"2021-10-07","conditions":"Chronic Kidney Diseases, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 1","enrollment":10},{"nctId":"NCT05549609","phase":"PHASE1, PHASE2","title":"A Study of XSTEM-VLU in Patients With Difficult-to-heal Venous Leg Ulcers","status":"RECRUITING","sponsor":"Xintela AB","startDate":"2022-10-26","conditions":"Venous Leg Ulcer","enrollment":6},{"nctId":"NCT06738576","phase":"PHASE1","title":"Allogeneic Use of Expanded Mesenchymal Stem Cells Derived From Adipose Tissue (HC106), Female Urinary Incontinence Women Over 50 Years Old","status":"RECRUITING","sponsor":"Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz","startDate":"2024-12-16","conditions":"Urinary Incontinence Stress","enrollment":60},{"nctId":"NCT06951074","phase":"PHASE2, PHASE3","title":"Insulin Producing Stem Cell Transplantation Clinical Trial in Type 1 Diabetes","status":"RECRUITING","sponsor":"Ain Shams University","startDate":"2025-04-01","conditions":"Stem Cells, Type 1 Diabetes","enrollment":20},{"nctId":"NCT04466007","phase":"PHASE2","title":"Safety and Efficacy of Allogeneic Adipose Tissue Mesenchymal Stem Cells in Diabetic Patients With Critical Limb Ischemia","status":"COMPLETED","sponsor":"Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz","startDate":"2021-01-11","conditions":"Limb Ischemia, Diabetic Foot","enrollment":90},{"nctId":"NCT06280092","phase":"EARLY_PHASE1","title":"Allogenic Adipose-derived Mesenchymal Stem Cells(AMSCs) for Epilepsy During Deep Brain Stimulation(DBS) Surgery","status":"RECRUITING","sponsor":"Sanjeet S. Grewal","startDate":"2024-12-23","conditions":"Epilepsy","enrollment":5},{"nctId":"NCT05018793","phase":"PHASE1","title":"Safety of Cultured Autologous Adult Adipose Derived Mesenchymal Stem Cell Versus Cultured Allogeneic Adult Umbilical-cord Derived Mesenchymal Stem Cell Intrathecal Injection for SCI","status":"RECRUITING","sponsor":"The Foundation for Orthopaedics and Regenerative Medicine","startDate":"2024-12-01","conditions":"Spinal Cord Injuries","enrollment":15},{"nctId":"NCT05018871","phase":"PHASE1","title":"Safety of Cultured Autologous Adult Adipose Derived Mesenchymal Stem Cell Intravenous Infusion for CP","status":"SUSPENDED","sponsor":"The Foundation for Orthopaedics and Regenerative Medicine","startDate":"2025-12","conditions":"Cerebral Palsy","enrollment":15},{"nctId":"NCT03449082","phase":"PHASE2","title":"Treatment of Intractable Common Extensor Tendon Injury Using Mesenchymal Stem Cells (Allo-ASC)","status":"COMPLETED","sponsor":"Seoul National University Hospital","startDate":"2018-03-15","conditions":"Lateral Epicondylitis","enrollment":30},{"nctId":"NCT05660824","phase":"PHASE4","title":"Effectiveness of Stromal Vascular Fraction (SVF) and Platelet -Rich Plasma (PRP) in Patients With Knee Osteoarthritis: Study Protocol for a Phase III, Prospective, Randomized, Controlled Multi-center Study.","status":"NOT_YET_RECRUITING","sponsor":"Adrien Schwitzguebel","startDate":"2025-07","conditions":"Osteoarthritis","enrollment":108},{"nctId":"NCT06893250","phase":"PHASE2, PHASE3","title":"Orthobiologic Treatment for Knee Osteoarthritis","status":"ENROLLING_BY_INVITATION","sponsor":"University Hospital of North Norway","startDate":"2024-09-23","conditions":"Osteoarthritis Knee","enrollment":160},{"nctId":"NCT05521672","phase":"PHASE1, PHASE2","title":"Clinical Trial to Evaluate if the Laparoscopic Administration of Cells Derived From the Fatty Tissue Can Improve the Inflammatory Stenosis in Patient With Crohn's Disease","status":"TERMINATED","sponsor":"Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz","startDate":"2022-10-24","conditions":"Stenosis; Bowel, Crohn Disease","enrollment":2},{"nctId":"NCT06843122","phase":"PHASE2","title":"Evaluation of the Safety and Efficacy of Live ASCs in the Treatment of Diabetic Foot (FOOTCELL)","status":"NOT_YET_RECRUITING","sponsor":"Medical University of Warsaw","startDate":"2025-03-08","conditions":"Diabetic Foot Ulcer","enrollment":105},{"nctId":"NCT06649864","phase":"PHASE1","title":"Adipose-Derived Mesenchymal Stem Cell for Preventing Biliary Complications","status":"NOT_YET_RECRUITING","sponsor":"Mayo Clinic","startDate":"2026-02","conditions":"Liver Transplant; Complications, Liver Diseases","enrollment":20},{"nctId":"NCT03379168","phase":"NA","title":"Efficacy of Micro-fragmented Adipose Tissue Injection for Knee Osteoarthritis.","status":"COMPLETED","sponsor":"Dustin L. Richter, MD","startDate":"2018-04-01","conditions":"Knee Osteoarthritis","enrollment":75},{"nctId":"NCT06805448","phase":"PHASE1, PHASE2","title":"Intraglandular Treatment With Adipose-derived Mesenchymal Stem Cells in Patients With Xerostomia Due to Sjögren's Disease","status":"RECRUITING","sponsor":"Rigshospitalet, Denmark","startDate":"2025-01-21","conditions":"Sjorgren's Syndrome","enrollment":40},{"nctId":"NCT06795620","phase":"PHASE1","title":"Tolerance Study of Allogeneic of Adipose Tissue Derived Mesenchymal Stroma/Stem Cells (AdMSC) Transplantation in Patients With Critical Limb Ischemia.","status":"NOT_YET_RECRUITING","sponsor":"University Hospital, Toulouse","startDate":"2025-01","conditions":"Critical Limb Ischemia","enrollment":10},{"nctId":"NCT03754465","phase":"PHASE2","title":"Clinical Study of ALLO-ASC-SHEET in Subjects with Diabetic Foot Ulcers","status":"COMPLETED","sponsor":"Anterogen Co., Ltd.","startDate":"2019-01-02","conditions":"Diabetic Foot Ulcer","enrollment":66},{"nctId":"NCT05974280","phase":"","title":"Study on the Treatment of Anal Fistulas Using Alofisel Versus Fat Autologous Stem Cells","status":"RECRUITING","sponsor":"Nantes University Hospital","startDate":"2024-01-02","conditions":"Crohn Disease, Anal Fistula","enrollment":20},{"nctId":"NCT05094011","phase":"PHASE1","title":"Evaluating Safety, Tolerability, and Efficacy of Autologous MitoCell Transplantation in Subjects With Idiopathic Parkinson's Disease","status":"NOT_YET_RECRUITING","sponsor":"Taiwan Mitochondrion Applied Technology Co., Ltd.","startDate":"2026-03-01","conditions":"Idiopathic Parkinson's Disease","enrollment":9},{"nctId":"NCT04223622","phase":"","title":"Effects of ASC Secretome on Human Osteochondral Explants","status":"COMPLETED","sponsor":"I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio","startDate":"2021-04-12","conditions":"Osteoarthritis","enrollment":36},{"nctId":"NCT05602116","phase":"PHASE1","title":"ASC - Autism Study","status":"COMPLETED","sponsor":"Cell to Cure ApS","startDate":"2023-06-09","conditions":"Autism Spectrum Disorder, Gastrointestinal Dysfunction, Leaky Gut Syndrome","enrollment":10},{"nctId":"NCT04661644","phase":"PHASE1, PHASE2","title":"Efficacy and Safety of Mesenchymal Stem Cell Clusters in Patients with Critical Limb Ischemia","status":"COMPLETED","sponsor":"S.Biomedics Co., Ltd.","startDate":"2020-11-04","conditions":"Critical Limb Ischemia","enrollment":20},{"nctId":"NCT05362786","phase":"PHASE1","title":"Bone Marrow-Derived Mesenchymal Stem Cell Therapy for Chronic Kidney Disease","status":"COMPLETED","sponsor":"LaTonya J. Hickson","startDate":"2022-07-01","conditions":"Chronic Kidney Diseases","enrollment":14},{"nctId":"NCT04847739","phase":"PHASE2","title":"Seeded Cells on Matrix Plug Treating Crohn's Perianal Fistulas (STOMP-II)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Avobis Bio, LLC","startDate":"2021-09-13","conditions":"Perianal Fistula, Crohn's Disease","enrollment":60},{"nctId":"NCT00815217","phase":"NA","title":"The Role of Lipoaspirate Injection in the Treatment of Diabetic Lower Extremity Wounds and Venous Stasis Ulcers","status":"WITHDRAWN","sponsor":"Washington D.C. Veterans Affairs Medical Center","startDate":"2009-02","conditions":"Diabetic Wounds, Venous Stasis Wounds","enrollment":""},{"nctId":"NCT03672825","phase":"PHASE1","title":"REcycled CartiLage Auto/Allo IMplantation","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2018-09-13","conditions":"Cartilage Defect","enrollment":25},{"nctId":"NCT06516419","phase":"NA","title":"Development of Products Based on Secretom From Stem Cell Conditioned Medium for Melasma Therapy","status":"RECRUITING","sponsor":"Dr.dr.Irma Bernadette, SpKK (K)","startDate":"2024-02-13","conditions":"Melasma","enrollment":90},{"nctId":"NCT04544215","phase":"PHASE1, PHASE2","title":"A Clinical Study of Mesenchymal Progenitor Cell Exosomes Nebulizer for the Treatment of Pulmonary Infection","status":"SUSPENDED","sponsor":"Ruijin Hospital","startDate":"2020-07-01","conditions":"Drug-resistant","enrollment":60},{"nctId":"NCT06509828","phase":"","title":"Expanded Access Protocol for STOMP-II Patients Who Were Unable to Receive Treatment Subsequent to Adipose Tissue Collection","status":"AVAILABLE","sponsor":"Avobis Bio, LLC","startDate":"","conditions":"Perianal Fistula Due to Crohn's Disease","enrollment":""}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":451,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Adipose Mesenchymal stem cells","genericName":"Adipose Mesenchymal stem cells","companyName":"Universidad Catolica Santiago de Guayaquil","companyId":"universidad-catolica-santiago-de-guayaquil","modality":"Biologic","firstApprovalDate":"","aiSummary":"Adipose Mesenchymal stem cells are a type of somatic cell supplemental therapy used to treat various conditions, including knee osteoarthritis, cartilage defects, and recurrent glioblastoma. They are derived from adipose tissue and have been studied in clinical trials for their potential therapeutic effects.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}